IL6 and cancer: Elevated circulating levels of certain inflammatory cytokines and angiogenic factors such as tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6), as well as metabolic growth hormones (leptin and insulin), have been associated with a higher risk of cancer recurrence and mortality in several solid tumors.